Angelo Andriulli

Q: What Schools Are Affiliated With Angelo Andriulli

Angelo Andriulli is affiliated with the following schools: University of California, Berkeley, Stanford University

Angelo Andriulli's AcademicInfluence.com Rankings

Angelo Andriulli

Computer Science

#9014

World Rank

#9472

Historical Rank

Computational Linguistics

#2106

World Rank

#2128

Historical Rank

Machine Learning

#3841

World Rank

#3887

Historical Rank

Artificial Intelligence

#4167

World Rank

#4225

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Angelo Andriulli's Degrees

Masters Artificial Intelligence Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Angelo Andriulli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Angelo Andriulli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies (2007) (978)
Genome-wide association identifies multiple ulcerative colitis susceptibility loci (2010) (621)
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014 (2014) (511)
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. (2005) (502)
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis (2010) (372)
European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. (2010) (278)
Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial (2007) (274)
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. (2012) (251)
Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials (2009) (250)
Randomized Controlled Trial of Botulinum Toxin Versus Laparoscopic Heller Myotomy for Esophageal Achalasia (2004) (248)
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways (2015) (233)
Pegylated interferon alpha‐2b as monotherapy or in combination with ribavirin in chronic hepatitis delta (2006) (217)
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia (2000) (214)
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. (2000) (212)
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study. (2007) (200)
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. (2002) (178)
Aberrant DNA Methylation in Non-Neoplastic Gastric Mucosa of H. Pylori Infected Patients and Effect of Eradication (2007) (174)
Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies (2012) (172)
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies (2018) (172)
Randomized study of two “rescue” therapies for helicobacter pylori-infected patients after failure of standard triple therapies (2001) (170)
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. (1996) (167)
Characteristics of hepatocellular carcinoma in Italy. (1998) (161)
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. (2007) (160)
Italian consensus guidelines for chronic pancreatitis. (2010) (155)
Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying (1998) (153)
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease (2016) (152)
Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers (2012) (150)
Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. (2006) (145)
Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study (2004) (144)
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. (2000) (141)
Gastrointestinal motility disorders in patients with inactive Crohn's disease. (1997) (141)
Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. (2007) (130)
Helicobacter pylori infection and growth delay in older children (1997) (127)
Clock Gene Expression Levels and Relationship With Clinical and Pathological Features in Colorectal Cancer Patients (2011) (127)
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar (2017) (124)
Predictors of failure of Helicobacter pylori eradication with the standard ‘Maastricht triple therapy’ (2001) (121)
Variants of CARD15 are Associated with an Aggressive Clinical Course of Crohn's Disease—An IG-IBD Study (2005) (121)
HLA class II favors clearance of HCV infection and progression of the chronic liver damage. (1999) (117)
Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study. (2013) (115)
Meta‐analysis: the outcome of anti‐viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis (2008) (115)
Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. (1999) (114)
Smoking as a Cofactor for Causation of Chronic Pancreatitis: A Meta-Analysis (2010) (114)
Outcome of chronic delta hepatitis in Italy: a long-term cohort study. (2010) (111)
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study (2005) (111)
Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. (1996) (108)
HCV and diabetes mellitus: evidence for a negative association (1998) (108)
ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer (2012) (105)
Changing pattern of chronic hepatitis D in Southern Europe. (1999) (104)
The predominance of hepatitis delta virus genotype I among chronically infected Italian patients (1997) (104)
Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. (2004) (104)
Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. (2013) (103)
Clinical Features of Reflux Esophagitis in Older People: A Study of 840 Consecutive Patients (2006) (101)
Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study. (2002) (100)
Anticardiolipin antibodies in patients with liver disease (1999) (99)
IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. (2004) (99)
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus – A GISC study (1999) (94)
The 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. (1998) (94)
Proton-Pump Inhibitors and Outcome of Endoscopic Hemostasis in Bleeding Peptic Ulcers: A Series of Meta-analyses (2005) (93)
Pancreatic Duct Stents in the Prophylaxis of Pancreatic Damage after Endoscopic Retrograde Cholangiopancreatography: A Systematic Analysis of Benefits and Associated Risks (2007) (92)
Polymorphism of the IRGM Gene Might Predispose to Fistulizing Behavior in Crohn's Disease (2009) (89)
Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia. (2017) (88)
Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors (2005) (87)
Proton‐pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non‐steroidal anti‐inflammatory drugs (2004) (86)
Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. (2010) (86)
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease (2013) (86)
A modified fast-track program for pancreatic surgery: a prospective single-center experience (2011) (84)
13C‐octanoic acid breath test for gastric emptying measurement (2000) (83)
The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal antiinflammatory drugs: The role of gastroprotective drugs (2003) (82)
Continuous Infusion Versus Bolus Administration of Steroids in Severe Attacks of Ulcerative Colitis: A Randomized, Double-Blind Trial (2007) (82)
Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis (2001) (77)
Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. (2005) (76)
Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma (2002) (75)
13C octanoic acid breath test (1998) (75)
Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. (2001) (73)
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study (2017) (73)
Determinants of relapse after a short (12 weeks) course of antiviral therapy and re‐treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection (2009) (71)
Clinical Trial on the Efficacy of a New Symbiotic Formulation, Flortec, in Patients With Irritable Bowel Syndrome: A Multicenter, Randomized Study (2008) (71)
Erythrocytes-Mediated Delivery of Dexamethasone in Steroid-Dependent IBD Patients—A Pilot Uncontrolled Study (2005) (71)
Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. (1999) (69)
High- Versus Low-Dose Proton Pump Inhibitors After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding: A Multicentre, Randomized Study (2008) (68)
Variants of OCTN1–2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis (2006) (68)
Helicobacter pylori infection may undergo spontaneous eradication in children: a 2-year follow-up study. (1998) (67)
Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients (2005) (65)
Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells. (2010) (65)
Intrafamilial transmission of hepatitis delta virus: molecular evidence. (1999) (65)
Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study (2001) (64)
Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites (2016) (63)
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. (2010) (63)
Investigation of Multiple Susceptibility Loci for Inflammatory Bowel Disease in an Italian Cohort of Patients (2011) (63)
Randomized study of different ‘second‐line’ therapies for Helicobacter pylori infection after failure of the standard ‘Maastricht triple therapy’ (2003) (63)
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. (1998) (62)
Fatal systemic venous air embolism during endoscopic retrograde cholangiopancreatography. (2009) (62)
Octreotide 24‐h prophylaxis in patients at high risk for post‐ERCP pancreatitis: results of a multicenter, randomized, controlled trial (2001) (62)
Randomised clinical trial: low‐volume bowel preparation for colonoscopy ‐ a comparison between two different PEG‐based formulations (2012) (61)
Treatment of antibiotic-resistant Helicobacter pylori. (1998) (60)
Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. (2006) (60)
Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. (2003) (60)
Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study (2008) (59)
Intrasphincteric injection of botulinum toxin is effective in long‐term treatment of esophageal achalasia (1998) (59)
Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas. (2018) (59)
Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice (2018) (58)
Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis (2003) (58)
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. (2016) (58)
Loss of Connectivity in Cancer Co-Expression Networks (2014) (58)
HCV genotypes in patients with liver disease of different stages and severity. (1997) (56)
A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C (2001) (56)
An optimized experimental protocol based on neuro-evolutionary algorithms: Application to the classification of dyspeptic patients and to the prediction of the effectiveness of their treatment (2005) (53)
Detection of abnormal lesions recorded by capsule endoscopy. A prospective study comparing endoscopist's and nurse's accuracy. (2006) (53)
Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection (2005) (52)
Histological Study of Alcoholic, Nonalcoholic, and Obstructive Chronic Pancreatitis (1992) (51)
Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study. (2013) (51)
Endoscopic ultrasonographic evaluation of patients with biopsy negative gastric linitis plastica. (1990) (51)
Fine-needle liver biopsy in patients with severely impaired coagulation. (2008) (50)
Radioimmunoassay of trypsin-like substance in human serum. (1980) (49)
Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy (2007) (49)
Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia. (1996) (49)
A randomized controlled trial of pegylated interferon α‐2a (40 KD) or interferon α‐2a plus ribavirin and amantadine vs interferon α‐2a and ribavirin in treatment‐naïve patients with chronic hepatitis C (2005) (49)
Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. (1995) (48)
Hepatitis C virus infection: a new bridge between hematologists and gastroenterologists? (1996) (48)
Changes in miR-143 and miR-21 Expression and Clinicopathological Correlations in Pancreatic Cancers (2012) (48)
Neoadjuvant chemo-radiotherapy for patients with borderline resectable pancreatic cancer: a meta-analytical evaluation of prospective studies. (2013) (48)
DNA Methyltransferases 1 and 3b Expression in Huh-7 Cells Expressing HCV Core Protein of Different Genotypes (2012) (48)
Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. (2006) (47)
SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation (2014) (47)
Ultrasonographic and biochemical parameters in the non‐invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis (2005) (46)
Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers. (1986) (46)
Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation. (1996) (45)
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. (2013) (45)
Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal (2000) (43)
Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: A meta‐analysis (2007) (43)
External Validation of Biochemical Indices for Noninvasive Evaluation of Liver Fibrosis in HCV Chronic Hepatitis (2005) (43)
Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin‐dependent) diabetes mellitus (1997) (42)
Tailoring the length of antiviral treatment for hepatitis C (2009) (42)
Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer. (2013) (41)
Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial. (1997) (41)
Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome (2015) (41)
CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases. (1986) (40)
HLA-DRB1 Alleles May Influence Disease Phenotype in Patients With Inflammatory Bowel Disease: A Critical Reappraisal With Review of the Literature (2005) (40)
enetic Susceptibility to Nonsteroidal Anti-Inflammatory Drug – Related astroduodenal Bleeding : Role of Cytochrome P 450 2 C 9 Polymorphisms (2007) (39)
Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour (2009) (39)
The association of MYO9B gene in Italian patients with inflammatory bowel diseases (2007) (38)
HCV and diabetes mellitus: evidence for a negative association. (1998) (38)
Association Study of a Polymorphism in Clock Gene PERIOD3 and Risk of Inflammatory Bowel Disease (2012) (38)
Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials. (2004) (38)
Coarse nodular US pattern in hepatic cirrhosis: risk for hepatocellular carcinoma. (2003) (38)
HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response (2016) (37)
To biopsy or not to biopsy. (2001) (37)
Usefulness of the Comprehensive Geriatric Assessment in Older Patients with Upper Gastrointestinal Bleeding: A Two-Year Follow-Up Study (2007) (37)
HLA and enteric antineuronal antibodies in patients with achalasia (2006) (37)
13C-octanoic acid breath test: a reliable tool for measuring gastric emptying. (1998) (37)
Mutual Antagonism between Circadian Protein Period 2 and Hepatitis C Virus Replication in Hepatocytes (2013) (37)
The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis. (1999) (36)
Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis. (2011) (36)
Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer. (1997) (36)
Short-term treatment duration for HCV-2 and HCV-3 infected patients. (2006) (36)
Digestive and Liver Disease (2011) (35)
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. (2004) (35)
Experts' opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.). (2005) (34)
Sustained virological responses following standard anti‐viral therapy in decompensated HCV‐infected cirrhotic patients (2009) (34)
Hypoechoic lesions in the ‘bright liver': A reliable indicator of fatty change. A prospective study (1992) (33)
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk (2016) (33)
Clinical features in familial cases of Crohn’s disease and ulcerative colitis in Italy: a GISC∗ study (2001) (33)
Contribution of IBD5 Locus to Clinical Features of IBD Patients (2006) (33)
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data (2002) (32)
Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition. (2008) (32)
Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group. (1999) (32)
Free-hand technique with ordinary antisepsis in abdominal US-guided fine-needle punctures: three-year experience. (1996) (32)
Familial expression of anti- Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study (2001) (32)
Patients with chronic renal failure are not at a risk of developing chronic peptic ulcers. (1985) (31)
Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. (2001) (31)
CARD15 genotyping in inflammatory bowel disease patients by multiplex pyrosequencing. (2003) (30)
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. (2000) (30)
Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients. (2007) (30)
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection. (2001) (30)
Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer (2018) (29)
Hepatic hydrothorax. Diagnosis and management. (1996) (29)
Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients (1999) (29)
Efficacy of 5 MU of interferon in combination with ribavirin for naïve patients with chronic hepatitis C virus: a randomized controlled trial. (2001) (28)
HCV chronic infection and CCR5-delta32/delta32. (2003) (28)
The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: an *IG-IBD study. (2004) (28)
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin. (2014) (28)
Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer. (2014) (28)
Usefulness of a Liver Biopsy in the Evaluation of Patients with Elevated ALT Values and Serological Markers of Hepatitis Viral Infection (2001) (27)
Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals? (2018) (27)
Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early‐onset patients with inflammatory bowel disease (2010) (26)
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs (2021) (26)
Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3. (2010) (26)
Genetics of inflammatory bowel disease: the beginning of the end or the end of the beginning? (2003) (26)
Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists. (1983) (26)
Comparison of a monoclonal antigen stool test (Hp StAR) with the 13C-urea breath test in monitoring Helicobacter pylori eradication therapy. (2005) (26)
13C-breath tests in hepatology (cytosolic liver function). (2004) (26)
Methodological problems and pitfalls of urea breath test. (1998) (25)
Hepatitis delta virus induces specific DNA methylation processes in Huh‐7 liver cancer cells (2013) (25)
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study (2017) (25)
Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: single centre experience (2014) (25)
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. (2017) (25)
Intraduodenal lipase activity in celiac disease assessed by means of 13C mixed-triglyceride breath test. (1998) (25)
13C-Octanoic acid breath test: valueless test for gastric emptying? (1998) (25)
Systematic review: interferon‐free regimens for patients with HCV‐related Child C cirrhosis (2017) (24)
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis. (2009) (24)
Contribution of artificial neural networks to the classification and treatment of patients with uninvestigated dyspepsia. (2003) (24)
Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis. (1999) (24)
Gross Pathologic Types of Hepatocellular Carcinoma in Italy (1999) (23)
Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis: A Randomized, Double-blind Sham-controlled Study (2013) (23)
The −A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease (2010) (23)
Antineutrophil cytoplasmic antibodies in inflammatory bowel disease (2000) (23)
Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels. (2012) (23)
Exploring the microbiota to better understand gastrointestinal cancers physiology (2018) (22)
Anti‐Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features (2004) (22)
Treatment of patients with HCV infection with or without liver biopsy (2004) (22)
Circulating trypsin-like immunoreactivity in chronic pancreatitis (1981) (22)
High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitis. (2002) (21)
Botulinum Toxin in Long-Term Therapy for Achalasia (1998) (21)
Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC* study (2001) (21)
Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis (2000) (21)
Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia (2016) (21)
Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease? (2009) (21)
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg‐interferon α‐2b and ribavirin (2010) (20)
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation (2015) (20)
Hydrothorax complicating cirrhosis in the absence of ascites. (1993) (20)
Dyspepsia and Helicobacter pylori infection: a prospective multicentre observational study. (2003) (20)
Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer (2020) (20)
HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. (1998) (20)
Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon (2012) (20)
Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus. (2005) (19)
Serum immunoreactive cationic trypsinogen response to secretin in normal subjects. (1983) (19)
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study. (2017) (19)
The polymorphism of multi-drug resistance 1 gene (MDR1) does not influence the pharmacokinetics of dexamethasone loaded into autologous erythrocytes of patients with inflammatory bowel disease. (2006) (19)
The expression of leucine-rich repeat gene family members in colorectal cancer (2012) (19)
The urea breath test: a non-invasive clinical tool for detecting Helicobacter pylori infection. (1995) (19)
Effect of regular and decaffeinated coffee on serum gastrin levels. (1986) (19)
"Appropriateness" or "prioritization" for GI endoscopic procedures? (2006) (18)
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs (2021) (18)
Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease (2015) (18)
Ranitidine bismuth citrate‐based triple therapies after failure of the standard ‘Maastricht triple therapy’: a promising alternative to the quadruple therapy? (2001) (18)
Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation (2004) (18)
Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI) (2016) (17)
Long‐term outcome of hepatitis B virus‐related Chronic Hepatitis under protracted nucleos(t)ide analogues (2013) (17)
Pattern Analysis of Serum alpha-fetoprotein in the Early Diagnosis of Hepatocellular Carcinoma in Liver Cirrhosis (1988) (17)
C octanoic acid breath test (1998) (17)
Trypsin-like immunoreactivity in the diagnosis of acute pancreatitis. (1980) (17)
Amylase to creatine clearance ratio in renal diseases. (1979) (17)
Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients (2016) (16)
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma (2019) (16)
X chromosome contribution to the genetic architecture of primary biliary cholangitis. (2021) (16)
Functional Implications of MicroRNAs in Crohn’s Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling (2017) (16)
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? (2001) (16)
Genome‐wide association study identifies an early onset pancreatic cancer risk locus (2020) (16)
Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer. (1996) (15)
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross‐sectional multicenter study (2017) (15)
SIRT1 and the Clock Gene Machinery in Colorectal Cancer (2012) (15)
Appropriateness of urea breath test: a prospective observational study based on Maastricht 2000 guidelines (2002) (15)
Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection (2009) (15)
Case Report: Fatal Ulcerative Panenteritis Following Colectomy in a Patient with Ulcerative Colitis (1999) (15)
Treatment of chronic hepatitis D with thymus-derived polypeptide thymic humoral factor-gamma 2: a pilot study. (2002) (15)
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms (2018) (15)
Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier. (2016) (14)
Hepatitis C virus, mitochondria and auto/mitophagy: exploiting a host defense mechanism. (2014) (14)
Transperineal ultrasonography: First level exam in IBD patients with perianal disease. (2016) (14)
Crohn’s Disease Localization Displays Different Predisposing Genetic Variants (2017) (14)
Minute and small early gastric cancers in a Western population: a clinicopathologic study. (1995) (14)
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation (2011) (14)
Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open‐labelled study (2004) (14)
Correlations among PPARγ, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer (2012) (14)
Subgroups of Patients with Crohn’s Disease Have Different Clinical Outcomes (1996) (14)
TNF‐α Polymorphisms in Primary Biliary Cirrhosis: A Northern and Southern Italian Experience (2009) (13)
Microscopic colitis progressed to collagenous colitis: a morphometric study. (1996) (13)
Genome‐wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility (2021) (13)
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation (2018) (13)
1185 ELTROMBOPAG IN CHRONIC LIVER DISEASE PATIENTS WITH THROMBOCYTOPENIA UNDERGOING AN ELECTIVE INVASIVE PROCEDURE: RESULTS FROM ELEVATE, A RANDOMISED CLINICAL TRIAL (2010) (13)
A different perspective on sofosbuvir‐ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital‐c network study (2018) (13)
Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy. (1989) (13)
Influence of sex and body size on pancreatic bicarbonate and enzyme output. (1984) (12)
The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy. (2019) (12)
Cruveilhier‐Baumgarten syndrome: An efficient spontaneous portosystemic collateral preventing oesophageal varices bleeding (1994) (12)
Overall acceptability and efficacy of commonly used bowel preparations for colonoscopy in Italian clinical practice. A multicentre prospective study. (2014) (12)
Epidemiology and diagnosis of hepatitis D virus (2012) (12)
Rifabutin-based ‘rescue therapy’ for Helicobacter infection in patients after failure of standard regimens (2000) (12)
Amoxicillin‐Tetracycline Combinations are Inadequate as Alternative Therapies for Helicobacter pylori Infection (2002) (11)
Exocrine Pancreatic Insufficiency, as Assessed by Fecal Elastase-1 Levels, in Diabetic Patients: An Estimate of Prevalence in Prospective Studies (2014) (11)
Does a single granuloma warrant a diagnosis of idiopathic granulomatous gastritis? (1993) (11)
Unawareness of HBV infection among inpatients in a Southern Italian hospital (2011) (11)
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis (2019) (10)
Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis (2020) (10)
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome (2014) (10)
Exploitation of host clock gene machinery by hepatitis viruses B and C. (2013) (10)
Variation in genes encoding for interferon λ‐3 and λ‐4 in the prediction of HCV‐1 treatment‐induced viral clearance (2014) (10)
Family occurrence of achalasia. (1995) (10)
Declining prevalence and increasing awareness of hepatitis C virus infection in Italy: a population-based survey (2017) (10)
Impact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: Association with IL33 gene variant. (2014) (10)
Serum trypsinlike immunoreactivity in cystic fibrosis. An aid in assessing progressive involvement of the pancreas. (1983) (10)
"Mixed" triglyceride breath test: methodological problems and clinical applications. (1998) (10)
Fundoplication after heller myotomy: a retrospective comparison between nissen and dor. (2011) (10)
Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis (2017) (9)
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology. (2021) (9)
Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin (2013) (9)
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C. (2014) (9)
On the role of CFTR, PSSR1 and PST1/SPINK1 in idiopathic chronic pancreatitis (2003) (9)
Retroperitoneal neurilemoma diagnosed by endosonographically guided fine needle aspiration (2006) (9)
A unifying working hypothesis for juvenile polyposis syndrome and Ménétrier's disease: specific localization or concomitant occurrence of a separate entity? (2012) (9)
CIRRHOSIS AND LIVER CANCER (1985) (9)
ORAL CYCLOSPORIN VS INFLIXIMAB IN PATIENTS WITH SEVERE ULCERATIVE COLITIS REFRACTORY TO IV STEROIDS. PRELIMINARY DATA OF A CONTROLLED, RANDOMIZED STUDY (2009) (8)
NOD2/CARD15 in healthy relatives of IBD patients. (2006) (8)
Association of Crohn's disease and ulcerative colitis with haplotypes of the MLH1 gene in Italian inflammatory bowel disease patients (2002) (8)
Diagnostic accuracy of serum cationic trypsinogen estimation for pancreatic diseases (1982) (8)
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients (2014) (8)
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy (2018) (8)
Risk of post-endoscopic retrograde cholangiopancreatography pancreatitis and ways to prevent it: old myths, a current need? The case of allopurinol. (2008) (8)
Does renal tubular dysfunction account for the enhanced CAmCCr ratio in acute pancreatitis (1980) (8)
Managing patients with nonvariceal upper gastrointestinal bleeding. (2004) (7)
Cerebellar metastasis as a unique presenting feature of gastric cancer. (2001) (7)
Artificial neural networks can classify uninvestigated patients with dyspepsia (2007) (7)
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. (2016) (7)
Early discontinuation of ribavirin in HCV‐2 and HCV‐3 patients responding to Peg‐interferon alpha‐2a and ribavirin (2009) (7)
MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma (2017) (7)
Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: a pilot study. (2007) (7)
Ranitidine bismuth citrate plus clarithromycin and metronidazole in a geographical area with high primary metronidazole resistance (1998) (7)
Etiological factors of chronic hepatitis in Italy: a 2014 national survey (2017) (7)
93 HCV genotype 2 and 3 can be cured by PEG-IFN-alfa-2B and RBV for 12 wks: A randomized controlled study (2004) (7)
Clinical evaluation of serum cationic trypsin-like immunoreactivity in patients with different pancreatic diseases (1980) (7)
The intelligent, painless, "germ-free" colonoscopy: A Columbus' egg for increasing population adherence to colorectal cancer screening? (2010) (7)
Bombesin releases gastrin but inhibits gastric secretion in rat (1981) (7)
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. (2021) (7)
Interplay between SOX9, beta-catenin and PPAR gamma activation in colorectal cancer (2013) (7)
Aminopyrine breath test (1994) (7)
Landmarks for dual biological therapy in inflammatory bowel disease: lesson from two case reports of vedolizumab in combination with ustekinumab. (2020) (7)
Focal ultrasound lesions in cirrhotic liver diagnosed as regenerative nodules by biopsy. A morphometric analysis. (1993) (7)
Evocative test of serum pancreatic enzymes to bombesin in chronic pancreatitis. (1986) (7)
Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines (2012) (7)
Original ContributionsPatterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying (1998) (7)
Endoscopic ultrasonography in eosinophilic infiltration of gastric wall. (1990) (7)
IL23R, ATG16L1, IRGM, OCTN1, and OCTN2 mRNA expression in inflamed and noninflamed mucosa of IBD patients. (2011) (7)
Hepatitis viruses exploitation of host DNA methyltransferases functions (2016) (7)
Neoadjuvant chemo-radiotherapy for patients with borderline resectable pancreatic cancer: A meta-analytical evaluation of prospective studies (2012) (6)
microRNA‐mRNA network model in patients with achalasia (2019) (6)
Linkage of ulcerative colitis to the pericentromeric region of chromosome 16 in Italian inflammatory bowel disease families is independent of the presence of common CARD15 mutations (2003) (6)
Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers (2017) (6)
Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3 (2018) (6)
Erratum: Genome-wide association identifies multiple ulcerative colitis susceptibility loci (2011) (6)
Hepatitis C Virus Clearance in Older Adults (2018) (6)
Treatment of steroid-naive ulcerative colitis (2009) (6)
New biologics in the management of Crohn’s disease: focus on certolizumab pegol (2009) (6)
P127 - Oral cyclosporin vs infliximab in patients with severe ulcerative colitis refractory to iv steroids. Preliminary data of a controlled, randomized study (2009) (6)
Monthly fluctuations of active duodenal ulcers (1984) (5)
Efficacy of lamivudine therapy in chronic delta hepatitis: A multicenter randomized controlled pilot study (2003) (5)
Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases. (2013) (5)
SEASONAL TREATMENT WITH RANITIDINE (1984) (5)
Safety and efficacy of switching from infliximab biosimilar CT-P13 to infliximab biosimilar SB2 in patients with inflammatory bowel disease. (2020) (5)
Dissecting genetic predisposition to inflammatory bowel disease: current progress and prospective application (2007) (5)
Gastric emptying of solids is delayed in celiac disease and normalizes after gluten-free diet (1998) (5)
Perendoscopic real-time assessment of pH improves detection of gastric preneoplastic conditions. (2013) (5)
Advance in molecular diagnostic tools for hepatitis B virus detection (2013) (5)
Co2- and H2 breath tests in the diagnosis of intestinal malabsorption. (1992) (5)
Pancreatic exocrine function tests. (1998) (5)
Polymorphism of Motilin Gene in Patients with Crohn's Disease (1998) (5)
8 FACTORS PREDICTIVE OF RELAPSE IN GENOTYPE 2 AND 3 PTS TREATED FOR 12 WEEKS WITH PEGIFN ALFA 2B AND WEIGHT BASED RIBAVIRIN COMBINATION (2008) (5)
Multicentre, dose-finding study of botulinum toxin for the therapy of esophageal achalasia (1998) (5)
First do no harm: power, oppression, and violence of liver biopsy. (2003) (4)
Expert Consensus Conference. The screening for hepatitis C virus infection in adults in Italy, May 5-6, 2005. (2006) (4)
Screening and treatment of portal vein thrombosis in cirrhosis. (2017) (4)
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV. (2007) (4)
Interobserver agreement of the Paris and simplified classifications of superficial colonic lesions: a Western study (2021) (4)
Relation between serum cathodic trypsinogen levels and exocrine pancreatic function. (1984) (4)
1170 IL28B C/C POLYMORPHISM IS PREDICTIVE OF SPONTANEOUS HCV RNA CLEARANCE IN PATIENTS WITH THALASSEMIA MAJOR (2010) (4)
UEG Week 2016 Poster Presentations (2016) (4)
A New Intraepithelial γδ T-Lymphocyte Marker for Celiac Disease Classification in Formalin-Fixed Paraffin-Embedded (FFPE) Duodenal Biopsies (2020) (4)
Microbiome Analysis of Mucosal Ileoanal Pouch in Ulcerative Colitis Patients Revealed Impairment of the Pouches Immunometabolites (2021) (4)
Dose-related effect of bombesin on serum cationic trypsinogen levels. (1983) (4)
506 Pegylated interferon alpha-2b monotherapy and in combination with ribavirin in chronic hepatitis delta (2006) (4)
P.07.13 SAFETY AND EFFICACY OF INFLIXIMAB BIOSIMILAR SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO UNDERWENT A SWITCH FROM INFLIXIMAB BIOSIMILAR CT-P13 (2019) (4)
Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma (2016) (4)
Clarithromycin accelerates gastric emptying by inducing powerful antral conractions (2000) (3)
P.324 Pegylated interferon alpha-2b monotherapy and in combination with ribavirin in chronic hepatitis delta (2006) (3)
[7] IN PTS WHO CLEAR HCVRNA AT WEEK 12, SVR IS HIGHER AFTER 72 THAN AFTER 48 WEEKS TX: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (RCT) (2007) (3)
Endoscopic removal of gallstone impacted in the rectum. (2011) (3)
MDR1 polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients (2006) (3)
Accuracy and Inter-Observer Agreement of the Nice and the Kudo Classifications of Superficial Colonic Lesions: A Comparative Study (2021) (3)
Germline Alterations in Patients With IBD-associated Colorectal Cancer. (2021) (3)
Closure of a gastrocutaneous fistula by a tulip-bundle technique. (2011) (3)
820 Erythrocytes-Mediated Delivery of Low Doses of Dexamethasone Revert Steroid-Dependency in Ulcerative Colitis. a Double-Blind, Sham-Controlled Study (2008) (3)
Mutational screening of the cationic trypsinogen gene in a large cohort of patients with aporadic chronic pancreatitis reveals novel DNA variants (1999) (3)
Skin is not a site of HCV replication in lichen planus (LP) (1998) (3)
Optimal dosage of ribavirin (2010) (3)
P.05.14 INFLIXIMAB VERSUS ADALIMUMAB IN CROHN'S DISEASE PATIENTS IN DAILY CLINICAL PRACTICE. A PROSPECTIVE SINGLE CENTER EXPERIENCE (2012) (3)
How evidence-based are current guidelines for managing patients with peptic ulcer bleeding? (2010) (3)
Re-treatment of patients with anti-HBe-positive chronic hepatitis B who relapsed after an initial course of lamivudine. (2003) (3)
Outcome of chronic hepatitis delta in Italy: A long-term cohort study (2009) (2)
662 HEMORRHAGIC COMPLICATIONS FOLLOWING INVASIVE PROCEDURES IN CIRRHOTIC PATIENTS WITH NORMAL OR ABNORMAL COAGULOPATHY. A PROSPECTIVE STUDY (2012) (2)
Somatostatin (SS) and Gabexate (GM) Are Ineffective in Preventing Post-ERCP Complications (2004) (2)
Transcriptome and Gene Fusion Analysis of Synchronous Lesions Reveals lncMRPS31P5 as a Novel Transcript Involved in Colorectal Cancer (2020) (2)
A Prolonged Follow-Up on the Efficacy and Safety of Infliximab Biosimilar CT-P13 in IBD Across Italy: The Prosit Cohort (2017) (2)
Tu1388 DEVELOPMENT AND VALIDATION OF A RISK STRATIFICATION SCORE FOR POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PANCREATITIS (2018) (2)
Pulmonary involvement in chronic pancreatitis (1984) (2)
Healthy and pro-inflammatory gut ecology plays a crucial role in the digestion and tolerance of a novel Gluten Friendly™ bread in celiac subjects: a randomized, double blind, placebo control in vivo study. (2022) (2)
Long-term follow-up of achalasic patients treated with botulinum toxin (1998) (2)
Amantadine in HCV chronic infection: A 6 months follow-up study (1998) (2)
Modeling interactions between human equilibrative nucleoside transporter-1 (hENT-1) and other factors involved in the response to gemcitabine treatment to predict of clinical outcomes, in pancreatic ductal adenocarcinoma (PDAC) patients. (2014) (2)
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk (2021) (2)
Bolus Versus Continuous High-Dose Omeprazole Infusion Combined with Endoscopic Hemostasis in Peptic Ulcer Bleeding. A Randomized, Multicenter, Italian Study (2007) (2)
Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection (2006) (2)
40 P Levofloxacin based triple therapy as second-line treatment for H. pylori infection after failure of standard triple therapy (2002) (2)
Gamma-glutamyltranspeptidase (GGTP): its relationship to other parameters for diagnosis of alcoholic liver disease. (1979) (2)
Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia. (2014) (2)
Multiple intrahepatic vascular shunts causing hyperammoniaemic encephalopathy in a patient without liver cirrhosis. (2006) (2)
[Prevalence of peptic ulcer in patients with various hepatopathies]. (1986) (2)
630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B (2009) (2)
Benign duodenocolic fistula: an unusual case of gastrointestinal bleeding. (1993) (2)
Oral beclomethasone dipropionate versus oral 5-aminosalicylic acid in the treatment of active ulcerative colitis: A randomised, 4 week, controlled study (2001) (2)
P291 Infliximab versus adalimumab in Crohn's disease patients in daily clinical practice. A prospective single center experience (2012) (2)
Randomized study on two “rescue” therapies for H. pylori infected patients after failure of standard “triple therapy” regimens (2000) (2)
OP005 The PROSIT cohort of infliximab biosimilar in IBD: a prolonged follow-up on the efficacy and safety across Italy. (2017) (2)
Letter: HBsAg kinetics‐guided interferon therapy for chronic hepatitis D – authors’ reply (2017) (2)
Affinity analysis of differentially expressed genes in hepatocytes expressing HCV core genotype 1b or 3a (2013) (2)
Endoscopic stenting for colorectal cancer obstruction as a bridge‐to‐surgery strategy (2020) (2)
Efficacy Versus Effectiveness of Octreotide in the Prophylaxis of Post-ERCP Pancreatitis (2007) (1)
Linkage to IBD1 locus does not identify specific clinical phenotypes in familial IBD patients (2000) (1)
1085 PEG-INTERFERON AND RIBAVIRIN IN HCV-RELATED CIRRHOTIC PATIENTS WITH PROFOUND THROMBOCYTOPENIA (2012) (1)
Update on Helicobacter pylori research. Diagnosis. (1997) (1)
371 OUTCOME OF CHRONIC HEPATITIS DELTA IN ITALY: A LONG TERM COHORT STUDY (2009) (1)
High sustained response rate after ribavirin + IFN retreatment of patients (PTS) who have failed a previous course of IFN with or without amantadine (2001) (1)
Splenic abscess secondary to penetrating gastric ulcer. (1998) (1)
Prevalence, Diagnosis and Clinical Course of Chronic Hepatitis-c Following Liver-transplantation in Children (1994) (1)
A randomised controlled trial on pegylated interferon alfa-2a (40kd) (Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV (2003) (1)
P.15.2 A MULTICENTRE PROSPECTIVE OBSERVATIONAL STUDY ASSESSING ACCEPTABILITY AND EFFICACY OF MOST COMMONLY USED BOWEL CLEANSING PREPARATIONS FOR COLONOSCOPY IN CLINICAL PRACTICE IN ITALY (2013) (1)
Sonographic classification of gallstones and outcome of extracorporeal shock wave lithotripsy. (1993) (1)
M1279 Smoking As a Co-Factor for Causation of Chronic Pancreatitis: A Meta-Analysis (2009) (1)
Do pancreatic adenocarcinomas and neuroendocrine neoplasms share genetic susceptibility a PANDoRA study (2017) (1)
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients (2014) (1)
INVERTED COLONIC DIVERTICULUM (ICD): REPORT OF TWO CASES AND LITERATURE REVIEW OF A NOT THAT UNUSUAL ENDOSCOPIC CHALLENGE. (2021) (1)
Rifabutin-based treatment as “rescue therapy” for H. Pylori infected patients after failure of standard regimens: A pilot study (1998) (1)
Dissecting the mucosal expression of human leucine-rich repeat family genes in inflammatory bowel disease patients. (2011) (1)
239 SUSTAINED VIROLOGICAL RESPONSE PREVENTS DEVELOPMENT AND DELAYS PROGRESSION OF PORTAL HYPERTENSION IN HCV-RELATED LIVER CIRROSIS (2010) (1)
Gallstone lithotripsy (GSL): results of the Technomed Sonolith 3000 multicenter trials. (1992) (1)
Erythrocytes as pharmacological carriers for corticosteroids and other drugs in patients with inflammatory bowel diseases (2011) (1)
Are HCV genotypes 2 and 3 the same or different? (2008) (1)
Value of real-time gastric juice analysis in upper gastrointestinal endoscopy. (2015) (1)
OC.06.4 IDENTIFICATION OF MIRNA TARGET TRANSCRIPTS BY COMBINED ANALYSIS OF MIRNA AND MRNA EXPRESSION LEVELS IN NORMAL AND NEOPLASTIC COLORECTAL TISSUES (2010) (1)
Abstracts of Papers Submitted to the 49th Annual Meeting of the American Pancreatic Association, October 31–November 3, 2018, Miami Beach, Florida (2018) (1)
Serum trypsinogen (2005) (1)
Hemangioma-like lesions in patients with chronic liver disease: diagnostic evaluation (2001) (1)
OC3.03.7 ERYTHROCYTES-MEDIATED DELIVERY OF LOW DOSES OF DEXAMETHASONE REVERT STEROID-DEPENDENCY IN ULCERATIVE COLITIS. A DOUBLE-BLIND, SHAM-CONTROLLED STUDY (2008) (1)
566 HEPATITIS B VIRUS (HBV) CORE PROMOTER (CP), PRECORE (PC) AND SURFACE MUTATIONS IN HEPATITIS D VIRUS (HDV) INFECTION: A MOLECULAR EPIDEMIOLOGY STUDY (2008) (1)
Dissection of the Crohn's Disease Transcriptome of 71 Loci Using Genome-Wide Microarrays (2011) (1)
Erratum: The —A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease (2010) (1)
The aminopyrine breath test. (1994) (1)
Lamivudine/interferon combination therapy for 12 months prevents the appearance of YMDD mutants in anti-hbe positive chronic hepatitis B patients: a controlled pilot study (2001) (1)
High dose of octreotide as a prophylaxis of post-ERCP pancreatitis. (2007) (1)
Guidelines for treatment of acute pancreatitis (1999) (1)
P621 Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study. (2017) (1)
Survival of Patients with Early Gastric Cancer Operated on for Cure (1990) (1)
MicroRNA and Colon-Cancer: The Circadian Clock Connection (2011) (1)
OC3.09.7 THE BIOENTERICS INTRAGASTRIC BALLOON: SHORT-TERM EFFICACY ON WEIGHT LOSS, INSULIN RESISTANCE, AND NON-ALCOHOLIC FATTY LIVER DISEASE (2008) (1)
Support Vector Machine Based on microRNA Expression Profiles to Predict Histological Origin of Ampullary Carcinoma: Case Report of a Patient Affected From Adenocarcinoma of the Papilla of Vater With Lynch Syndrome (2016) (1)
ROLE OF microRNA IN THE PATHOGENESIS OF COLORECTAL CANCER: POSSIBLE INVOLVEMENT OF miRNA-143 AND miRNA-21 (2009) (1)
Genetic variability of the ABCC2 gene and overall survival in pancreatic cancer (2018) (1)
Corrigendum: Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms [Carcinogenesis, 39, 3, (2018), (360-367)] DOI: 10.1093/carcin/bgx150 (2018) (1)
The use of diuretics in preventing ascites recurrence (1988) (1)
The specialty of gastroenterology: between a past of excellence and a somewhat uncertain future. (2010) (1)
54 kDa protein, but not 116 kDa protein, may be considered a serological marker of Helicobacter pylori positive gastric carcinoma (1998) (1)
A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis (2002) (1)
High SVR rate in HCV pts with normal or increased ALT: A controlled study with IFN alpha 2B and ribavirin (2003) (1)
M1257 Effect of the Bioenterics® Intragastric Balloon On Weight, Insulin Resistance, and Liver Steatosis in Obese Patients (2009) (1)
Metastatic melanoma: endoscopy as aid to earlier in vivo diagnosis of gastrointestinal involvement. A case report. (1996) (1)
[Primary hepatocarcinoma. Diagnostic imaging and chemoembolization]. (1993) (1)
Transperineal ultrasound (TPUS) in pediatric perianal disease (2014) (1)
Reply to Dr. Barkun's Letter (2005) (1)
Predictors of failure of Helicobacter pylori with the standard “Masstricht triple therapy” (2001) (1)
Su1764 Dissecting the Role of Unfolded Protein Response Pathway in Inflammatory Bowel Disease: In Silico mRNA-miRNA Co-Expression Analysis (2013) (1)
Lamivudine retreatment of pts who have relapsed after a previous course of lamivudine with or without interferon (2002) (0)
S1540: Laterally Spreading Tumors (LST) of the Colon: What Is the Role of Endoscopic Mucosal Resection (EMR) in the Endoscopic Submucosal Dissection (ESD) Era? (2010) (0)
Circulating levels of cytokines, chemokines and growth factors in patients with achalasia (2021) (0)
[Clinico-endoscopic prognosis of peptic ulcers after 1 month of treatment with cimetidine]. (1980) (0)
Serum antiglyadin and antiendomysium antibodies in the follow up of children with coeliac disease (1999) (0)
The \ldNUD-look\rd study: An italian multicenter observational study of non ulcer dyspepsia: Does helicobacter pylori eradication improve symptoms? (2000) (0)
Cancer sniffer dog: how can we translate this peculiarity in the laboratory medicine? Results of a pilot study on gastrointestinal cancer. (2017) (0)
Pancreatic steatorrhea and pulmonary tuberculosis (1988) (0)
P.17.8 CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTOR OF RESPONSE IN HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES (2014) (0)
[Intestinal ischemia: nosographic framework and risk factors]. (1990) (0)
Su1768 Genetic Risk Profiling of Complicated Disease Course in Crohn's Disease Patients (2013) (0)
[Effects of normal-caffeine and decaffeinated coffee on serum levels of total gastrin (G1-34), gastrin 1-17 and pepsinogen I]. (1986) (0)
T.N.15 Unawareness of Hbv Infection in Hospitalized Patients in Southern Italy (2010) (0)
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms. (2018) (0)
Prospective evaluation of the diagnostic efficacy of a mathematical model in acute pancreatitis (1980) (0)
Role of II generation contrast-enhanced ultrasonography (CEUS) in diagnosis of pacreatic lesions (2008) (0)
Ranitidine bismuth citrate (RBC) plus amoxycillin and tinidazole as second-line therapy for H. pylori infection after fallure of the standard “masstricht triple therapy” (2001) (0)
1086 A SUBSTANTIAL PROPORTION OF NAIVE HCV-1 INFECTED PATIENTS WITH CHRONIC INFECTION MAY BENEFIT FROM CURRENT STANDARD THERAPY WITH PEG-INTERFERON AND RIBAVIRIN (2012) (0)
Symptoms in functional dyspepsia: Role of H. pylori infection and delayed gastric emptying (1998) (0)
Re‐treatment of patients with anti‐HBe‐positive chronic hepatitis B who relapsed after an initial course of lamivudine (2003) (0)
Antiviraltherapyincompensated anddecompensatedcirrhotic patientswithchronicHCV infection (2009) (0)
Does renal tubular dysfunction account for the enhanced CAm/CCr ratio in acute pancreatitis? (1980) (0)
PC.01.6 MANAGEMENT OF HCC IN ELDERLY PATIENTS: AN ITALIAN “IN FIELD” EXPERIENCE (2014) (0)
PA.242 ROLE OF 2ND GENERATION CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) IN THE DIFFERENTIAL DIAGNOSIS OF BILIARY DUCT DISEASES (2008) (0)
P.10.3: Mortality in Upper Gastrointestinal Bleeding in Italy: Data from National Survey (2017) (0)
P.12.6 ADHERENCE TO SCREENING COLONOSCOPY IN A HIGH RISK POPULATION, FIRST-DEGREE RELATIVES OF PATIENTS WITH COLORECTAL CANCER (2012) (0)
Contributions of food, bile and pancreatic juice to intestinal adaptation in rats (1985) (0)
Administration of autologous erythrocytes loaded with dexamethasone 21-phosphate is effective in steroid-dependent IBD (2003) (0)
Bran in diverticular disease—Fact or fancy? (1982) (0)
Whole Exome Sequencing of very early onset ulcerative colitis patients identifies new variants in candidate genes (2015) (0)
Response to Lin (2009) (0)
A two-year follow-up study of achalasic octo-nonagerians treated with botulinum toxin (2006) (0)
Mo1448 Identification and Validation of an Individual Risk Score for Acute Post-ERCP Pancreatitis (2011) (0)
125 HEPATITIS DELTA VIRUS (HDV) INDUCES SPECIFIC DNA METHYLATION EVENTS TOWARDS MALIGNANCY IN HEPATOMA CELLS (2013) (0)
Correction to: A New Intraepithelial γδ T-Lymphocyte Marker for Celiac Disease Classification in Formalin-Fixed Paraffin-Embedded (FFPE) Duodenal Biopsies (2020) (0)
Response to Garcia-Cano (2008) (0)
URINARY IMMUNOREACTIVE TRYPSIN IN PANCREATIC CANCER (1980) (0)
Role of transperineal ultrasonography (TPUS) in follow up of IBD patients with perianal disease (2016) (0)
P.184 HEMODYNAMIC INSTABILITY AFFECTS CLINICAL OUTCOMES IN PATIENTS WITH NONVARICEAL UPPER GI BLEEDING (NVUGIB): ITALIAN RESULTS OF THE INTERNATIONAL “ENERGIB” STUDY (2010) (0)
438 HEPATITIS DELTA VIRUS UPREGULATES DNMT3B THROUGH STAT3 ACTIVATION IN HUH-7 CELLS (2012) (0)
[Early gastric cancer. Survival and prognostic factors in 95 consecutive cases]. (1991) (0)
The Range of ERCP Complications. Author's reply (2008) (0)
CS1.6 RADIO FREQUENCY THERMAL ABLATION VS PERCUTANEOUS ETHANOL INJECTION FOR SMALL HEPATOCELLULAR CARCINOMA IN CIRRHOSIS: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2008) (0)
[Dyspepsia: a reappraisal problem]. (1998) (0)
P1128 A MODEL TO ESTIMATE A PRIORI THE PROBABILITY OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-INTERFERON AND RIBAVIRIN FOR PATIENTS WITH HCV-1 INFECTION (2014) (0)
Multiple Genetic Testing to Explain Intolerance to Azathioprine (2006) (0)
[Osteoarticular manifestations during liver and gastrointestinal diseases]. (1994) (0)
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk. (2020) (0)
The PANcreatic Research (Pandora) Consortium: An update. (2013) (0)
Forecasting liver disease burden based on a real life cohort of the linked to care patients in Italy. Does the ‘underwater portion of the iceberg’ matter to reach the WHO HCV eliminating goals in the high HCV prevalent countries? (2018) (0)
COMPARISON BETWEEN SECOND GENERATION CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF PANCREATIC SOLID LESIONS (2009) (0)
P.231 Outcome of decompensated hepatitis C virus-related cirrhotic patients treated with peg-interferon alpha-2b and ribavirin. A controlled study (2006) (0)
PA.218 DIFFERENT ENDOTHERAPY PROCEDURES HAD DIFFERENT IMPACT ON REBLEEDING AND DEATH RATE FROM ULCER BLEEDING WITH HIGH RISK STIGMATA: A POST HOC ANALYSIS FROM A RANDOMIZED CLINICAL TRIAL (2008) (0)
P.10.1: Transfusion Strategy and Death Risk in Patients with Acute Non-Variceal Upper Gastro Intestinal Bleeding (NV-UGIB) in Italy: A Prospective Multicenter Observational Study (2016) (0)
Does genotype affect the course of HCV infection (1995) (0)
Abnormal antroduodenal motility in patients with ulcerative colitis (1998) (0)
Role of 2ND generation contrast-enhanced ultrasonography (CEUS) in the differential diagnosis of biliary duct diseases (2008) (0)
The C-13-urea breath test (UBT) correlates with the bacterial load ansi the severity of inflammation in H-pylori (HP) gastritis (1997) (0)
EUS-FNA ACCURACY FOR DIAGNOSIS OF CPT WITH MALIGNANT BEHAVIOUR (2009) (0)
P.10.10: Mortality Causes from Acute Upper Gastrointestinal Bleeding: A Prospective Multicentre Observational Study (2017) (0)
Prevalence of helicobacter-pylori infection in school-children in countries with high and low socioeconomic-status and different trends in incidence of gastric-cancer (1995) (0)
OC.08.2 RESULTS OF A SCREENING PROGRAM DEVOTED TO FIRST DEGREE RELATIVES OF CRC PATIENTS: 3 YEARS EXPERIENCE (2014) (0)
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study (2017) (0)
Polyacrylamide amylase isoenzymes in patients with symptomatic and asymptomatic hyperamylasemia (1979) (0)
Carman, W F see Jazayeri, M. Carnot, F see Lebray, P. Caronia, S, McGarvey, M J, Goldin, R D &. Foster, G R. Negative correlation between intrahepatic expression of hepatitis C antigens and apoptosis despite high-level expression of Fas ... (2004) (0)
240 SUSTAINED VIROLOGICAL RESPONSE IMPROVES SURVIVAL IN HCV-RELATED LIVER CIRROSIS WITH PORTAL HYPERTENSION (2010) (0)
Prophylactic treatment of bleeding oesophageal varices by endoscopic sclerotherapy (1985) (0)
Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation―Authors' reply (2017) (0)
Long-Term HDV-RNA Suppression - HBsAg Clearance in Chronic Hepatitis D Following Interferon Therapy (2014) (0)
P844 NGS to investigate genetic predisposition to colon cancer in patients with colon cancer over inflammatory bowel disease (2018) (0)
Early discontinuation of ribavirin in HCV genotype 2 and 3 patients undergoing short-treatment duration with Peg-interferon alfa 2a and ribavirin (2007) (0)
OC.10.1 THE USE OF PRE-ENDOSCOPIC INTRAVENOUS PROTON PUMP INHIBITORS (PPIS) HAD NO IMPACT ON CLINICAL OUTCOMES IN ACUTE UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE MULTICENTER ITALIAN COHORT STUDY (2020) (0)
Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A/P16) Polymorphisms and Risk of Pancreatic Neuroendocrine Tumors (2015) (0)
Hyperechoic hepatocellular carcinoma (HCC) smaller than 3 cm occurring in liver cirrhosis: Prevalence and statistical correlations in 419 consecutive patients (2001) (0)
W1215 Role of Naked Cuticle Homolog 1 Gene on Chr 16q12 in Inflammatory Bowel Disease (2010) (0)
Sustained response rate to amantadine plus interferon is higher than that to interferon alone (2000) (0)
Anti-saccharomyces cerevisiae mannan (ASCA) antibodies in inflamatory bowel disease (IBD) (2000) (0)
Addendum: Palmieri, O. et al. Functional Implications of MicroRNAs in Crohn’s Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling. Int. J. Mol. Sci. 2017, 18, 1580 (2017) (0)
[New trends in the treatment of gastrinoma]. (1985) (0)
OC.04.5 A MODEL TO PREDICT SUCCESS FOLLOWING PEG-INTERFERON AND RIBAVIRIN THERAPY FOR PATIENTS WITH HCV-1 INFECTION (2014) (0)
Transabdominal ultrasound-guided pancreatic biopsy: a neglected but safe, effective and inexpensive procedure that needs to be re-juvinalized (2021) (0)
Mutations in cystic fibrosis transmembrane conductance regulator (CFTR), cationic trypsinogen (PRSS1), and pancreatic secretory inhibitor (PSTI/SPINK1) genes in alcoholics with either chronic pancreatitis or liver disease (2003) (0)
Rabeprazole is more rapid than omeprazole in providing symptoms relief in oesophagitis patients (2003) (0)
OC.14.2 PREDICTIVE FACTORS OF MORTALITY IN ACUTE GASTROINTESTINAL BLEEDING IN ITALY (AUGIB): A NEW PRE-ENDOSCOPY PROGNOSTIC MODEL FROM A MULTICENTER STUDY (2018) (0)
Continuous infusion versus bolus administration of 6-methyl-prednisolone in severe attacks of ulcerative colitis. A randomised double-blind trial (2006) (0)
A PCR-based method for the diagnosis of Enterobius vermicularis in stool samples, specifically designed for clinical application (2022) (0)
Identification of recessively inherited genetic variants for pancreatic cancer risk (2021) (0)
Correction to: Accuracy and inter-observer agreement of the nice and kudo classifications of superficial colonic lesions: a comparative study (2021) (0)
T06.02.7 SAFETY AND LONG TERM OUTCOME OF SELF EXPANDIBLE METALLIC STENT AS BRIDGE-TO-SURGERY FOR OCCLUSIVE COLORECTAL CANCER (2020) (0)
P.03.17 PERCUTANEOUS ULTRASOUND FINE NEEDLE BIOPSY IN SOLID PANCREATIC LESIONS (2019) (0)
Inflammatory bowel diseeses are associated with the DNA repair gene MLH (2000) (0)
T1717 The Combined Analysis of miRNA and mRNA Expression Levels in Normal and Neoplastic Colorectal Tissues Allows the Identification of Putative miRNA Target Transcripts (2010) (0)
T01.01.7 THE USE OF A SPECIALIZED BLEEDING-MANAGEMENT TEAM HAD NO IMPACT ON MORTALITY FOR ACUTE UPPER GASTROINTESTINAL BLEEDING: AN ITALIAN PROSPECTIVE MULTICENTER COHORT STUDY (2020) (0)
Repeat diagnostic paracentesis is unlikely to alter the management of Spontaneous Bacterial Peritonitis (2013) (0)
Potentially flawed interpretation of data. Authors' reply (2005) (0)
Abstract 3411: Rare BRCA2 K3326X increases susceptibility to sporadic pancreatic ductal adenocarcinoma: a PANDoRA study (2017) (0)
Methylation study of CDH1, P16, APC and MLH1 genes promoter along multistep gastric carcinogenesis (2006) (0)
Management of Patients with Genotype 3 Chronic Hepatitis C: Can we Change the Duration of Therapy? (2010) (0)
Acknowledgment of 2010 Reviewers (2011) (0)
Comparison between HCVRNA AND E1/E2 antibodies in patients on IFN treatment (1998) (0)
24-Hour prophylaxis with octreotide in high-risk patients for post-ERCP pancreatitis: Results of a multicentre, randomized, controlled trial (2000) (0)
HCV genotype 1a and 1b: Similarities and differences in clinical features, therapeutic outcome and predictors of response (2014) (0)
Comparison of safety and accuracy of ultrasound-guided versus ultrasound-assisted biopsy with 18- or 16-gauge needle in diffuse liver diseases (2008) (0)
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies (2018) (0)
emostatic balance in patients with liver cirrhosis : eport of a consensus conference nder the auspices of the Italian Association for the Study of Liver Diseases AISF ) and the Italian Society of Internal Medicine (2016) (0)
OC.04.3 GENETIC PREDISPOSITION TO COLON CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: NGS APPROACH TO IDENTIFY HIGH RISK PATIENTS (2019) (0)
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms (vol 39, pg 360, 2018) (2018) (0)
< < Nlixed > ) tviglycevide bveath test : melhodological pvoblems and clinical applicalions (2016) (0)
Relevance of hepatitis C virus infection in monoclonal gammopathy (1995) (0)
P448 Polymorphisms in IL-33, IL1RL1 genes and risk of inflammatory bowel disease (2012) (0)
Preoperative biliary drainage and surgical outcome after pancreaticoduodenectomy (2013) (0)
TOPIC HIGHLIGHT (2009) (0)
[Electrogastrography. Evolution and clinical applications]. (1997) (0)
[Endoscopic sclerosis of esophageal varices for the prevention of re-bleeding: our experience]. (1985) (0)
I test genetici nel cancro del colon (2008) (0)
P.05.11: Role of Transperineal Ultrasonography (TPUS) in follow up of IBD Patients with Perianal Disease (2017) (0)
0542: Use of Contrast Enhanced Ultrasonography (CEUS) in the Assessment of Focal Liver Lesions in Pediatric Patients (2009) (0)
The PANcreatic DISEASE ReseArch (PANDoRA) consortium: an update (2013) (0)
Randomized comparison of amoxicillin/tetracycline based triple therapies for H. Pylori (1998) (0)
Age at diagnosis does not significantly influence Crohn's disease (CD) phenotype (2003) (0)
Optimization of direct antiviral agent treatment schedule in hepatitis C virus genotype 3 infection: an Italian, multicentetric experience in real-life setting (2017) (0)
Need for colectomy in Ulcerative Colitis (UC) (2003) (0)
Fasting cycles potentiates the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models (2014) (0)
[Supramammary hematoma due to rupture of the varices of the superficial collateral circulation in a patient with cirrhosis]. (1976) (0)
To the Editor (2001) (0)
Polymorphic variants within non-coding RNA and risk of pancreatic ductal adenocarcinoma (2020) (0)
Forecasting liver disease burden (2018) (0)
[Seasonal therapy of duodenal ulcerative disease]. (1986) (0)
Contribution of HLA complex to the disease phenotype in patients with ulcerative colitis (1998) (0)
Altered Dosage or Durations of Current Antiviral Therapy for HCV Genotypes 2 and 3 (2011) (0)
OC1.10.2 INJECT AND CUT TECHNIQUE OF ENDOSCOPIC MUCOSAL RESECTION IS A SAFE AND RADICAL TREATMENT FOR NON POLYPOID COLORECTAL LESIONS (2008) (0)
AISP - 28th National Congress. Verona (Italy). October 28-30, 2004 (2004) (0)
Potent effect of bombesin infusion on serum cationic trypsinogen and gastrin levels (1981) (0)
P729 HCV GENOTYPE 1A AND 1B: SIMILARITIES AND DIFFERENCES IN CLINICAL FEATURES, THERAPEUTIC OUTCOME AND PREDICTORS OF RESPONSE (2014) (0)
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (2021) (0)
OC1.11.6 ROLE OF SECOND GENERATION CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) IN DIAGNOSIS OF PANCREATIC LESIONS (2008) (0)
Predictors of failure of H. pylori infection after the standard “Maastricht triple therapy” (2001) (0)
P.61 IL23R, ATG16L1, IRGM, AND OCTNS MRNA EXPRESSION IN INFLAMED AND NON-INFLAMED MUCOSA OF IBD PATIENTS (2010) (0)
Diagnosis of liver nodules observed in cirrhotics during ultrasound screening for early detection of hepatocellular carcinoma (2001) (0)
P.11.11: Patients’ Acceptance of Injection Experience with Smartject Autoinjector in Ulcerative Colitis (2017) (0)
V1.2.5 SELF-EXPANDING METAL STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION: A SINGLE CENTRE EXPERIENCE (2008) (0)
US-guided fine-needle biopsy of early HCC: Multicenter Italian study (2003) (0)
Untoward effect of anti-TNF therapy in Crohn's disease — A case report (2000) (0)
P117 Functional implications of microRNAs in Crohn's disease revealed by integrating microRNA and messenger RNA expression profiling. (2017) (0)
P.181 ENDOSCOPIC TREATMENT OF NONVARICEAL UPPER GI BLEEDING (NVUGIB): ITALIAN RESULTS OF THE INTERNATIONAL “ENERGIB” STUDY (2010) (0)
W1216 IL23R, ATG16L1, IRGM, and Octns mRNA Expression in Inflamed and Non-Inflamed Mucosa of IBD Patients (2010) (0)
Reply: (2008) (0)
Endoscopic Dual Versus Monotherapy in Patients Bleeding from High-Risk Peptic Ulcers (2009) (0)
[Antisecretory drugs, hypergastrinemia and hyperplasia of enterochromaffin-like cells (ECL)]. (1991) (0)
Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon (2012) (0)
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” Study (2008) (0)
P.02.16 ROLE OF ABDOMINAL AND BOWEL ULTRASOUND IN LYNCH SYNDROME, FAMILIAL ADENOMATOUS POLYPOSIS AND OTHER MINOR HEREDITARY SYNDROMES (2019) (0)
Changes in MicroRNAs Expression and Clinical Associations in Patients with Neuroendocrine Pancreatic Tumors (2012) (0)
Erratum: Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy (European Journal of Gastroenterology and Hepatology (2018) 30 (676-681) DOI: 10.1097/MEG.0000000000001099) (2019) (0)
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM-BRANCH DUCT TYPE (IPMN-BD): A THIN THREAD BETWEEN SURGERY AND CONSERVATIVE FOLLOW-UP (2009) (0)
P.24 PATTERN OF CONCURRENT MEDICATION USE IN ITALIAN PATIENTS WITH NONVARICEAL UPPER GI BLEEDING (NVUGIB): RESULTS OF THE INTERNATIONAL “ENERGIB” STUDY (2010) (0)
USE OF CONTRAST ENHANCED ULTRASONOGRAPHY (CEUS) IN THE ASSESSMENT OF FOCAL LIVER LESIONS IN PEDIATRIC PATIENTS (2009) (0)
Card15 Genotyping in Inflammatory Bowel Disease Patients (2003) (0)
257 Liver transplantation (OLT), compared to percutaneous ethanol injection (PEI), assures better survival in patients with “early HCC”: a controlled, multicenter study (2003) (0)
P144 Regularized Least Squares Classifiers May Predict Crohn's Disease From Profiles of Songle Nucleotide Polymorphisms (2007) (0)
REPLACE CELIOTOMY IN PREDICTING STAGE AND RESECTABILITY OF GASTRIC CARCINOMA ( GC ) ? (0)
Reply to "triple or dual therapy for HCV-1 naive patients? Optimizing selection tools". (2014) (0)
P.1.45: IDENTIFICATION AND VALIDATION OF AN INDIVIDUAL RISK SCORE FOR ACUTE POST-ERCP PANCREATITIS (2011) (0)
A controlled trial on treatment of patients with HCV infection and abnormal liver function tests with or without liver biopsy (2003) (0)
[Treatment of primary hepatocarcinoma with chemoembolization and alcohol injection. Personal experience]. (1994) (0)
T-47 Thrombocytopenia and neutropenia during peginterferon plus ribavirin combination therapy in cirrhotic patients with HCV infection (2012) (0)
PA.114 COMPARISON OF SAFETY AND ACCURACY OF ULTRASOUND-GUIDED VERSUS ULTRASOUND-ASSISTED BIOPSY WITH 18- OR 16-GAUGE NEEDLE IN DIFFUSE LIVER DISEASES (2008) (0)
OC.02.4 CLINICAL OUTCOMES OF PATIENTS WITH NONVARICEAL UPPER GI BLEEDING (NVUGIB): ITALIAN RESULTS OF THE INTERNATIONAL “ENERGIB” STUDY (2010) (0)
11 IDENTIFICATION OF THE MICRORNAS EXPRESSION PROFILE IN COLORECTAL CANCER PATIENTS AND CORRELATION WITH CLINICO-PATHOLOGICAL DATA (2010) (0)
ORIGINAL CONTRIBUTIONS Inflammatory Bowel Disease Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study (2008) (0)
Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer (2018) (0)
Tu1156 Genome-Wide Expression Profiling of Idiopathic Achalasia Patients (2015) (0)
P.10.8: Mortality from Acute Upper Gastrointestinal Bleeding (UGIB): The Role of the Organizational and Health Care Course: A Prospective Multicentre Observational Study in Italy (2017) (0)
OC.01.3 ROLE OF NAKED CUTICLE HOMOLOG 1 GENE ON CHR 16Q12 IN INFLAMMATORY BOWEL DISEASE (2010) (0)
P078 Erythrocytes-Mediated Delivery of Dexamethasone in Patients With Mild to Moderate Ulcerative Colitis Refractory to Mesalamine. A Randomised-Controlled Study (2007) (0)
Trypsinogen cationic gene mutations in patients with non-alcoholic non-hereditary chronic pancreatitis: Results of a european multicentre study (2001) (0)
Interobserver agreement of the Paris and simplified classifications of superficial colonic lesions: a Western study (2021) (0)
[Endoscopic and intraoperative ultrasonography in staging of stomach neoplasms]. (1992) (0)
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma and effect of starvation in pancreatic cancer cell lines [forthcoming] (2015) (0)
CHRONIC DELTA INFECTION IN ITALY - ANALYSIS OF GENOTYPES (1994) (0)
POST-ERCP PANCREATITIS: SEARCH FOR THE HOLY GRAIL OF DRUGS TO PREVENT THIS COMPLICATION CONTINUES; THE QUEST TO UNDERSTAND RISK FACTORS IS FURTHER MUDDIED (2003) (0)
T06.02.10 YOUNG ONSET COLORECTAL CANCER: IDENTIFICATION OF A NEW DELETERIOUS VARIANT IN ATM (2020) (0)
Segmental motor abnormalities of the distal oesophagus. (1994) (0)
hepatitis C Tailoring the length of antiviral treatment for (2010) (0)
P.10.9: Outpatient Management of Patients with Glasgow-Blatchford Bleeding Score Low-Risk Upper-Gastrointestinal Hemorrhage: A Multicenter Validation Study in Italy (2017) (0)
OC.11.5 TRIGGER AND TARGET TRANSFUSION STRATEGY IN PATIENTS WITH NON-VARICEAL ACUTE UPPER GASTROINTESTINAL BLEEDING (NV-AUGIB): A PROSPECTIVE MULTICENTRE OBSERVATIONAL STUDY (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Angelo Andriulli?

Angelo Andriulli is affiliated with the following schools:

Angelo Andriulli's Academic­Influence.com Rankings

Angelo Andriulli's Degrees

Similar Degrees You Can Earn

Why Is Angelo Andriulli Influential?

Angelo Andriulli's Published Works

Published Works

What Schools Are Affiliated With Angelo Andriulli?

Angelo Andriulli's AcademicInfluence.com Rankings